























Acute effect of energy boost dietary supplement on 
P3 waveform: double blind, placebo controlled study
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Human cognition may be enhanced by energy drinks containing caffeine and/or other stimulants, which are thought to improve 
attentional as well as motor performance, and reduce reaction times. Due to the fact that literature shows that even low doses of 
caffeine may improve cognitive performance, we investigated an acute effect of a single dose of a caffeinated energy dietary supplement, 
on attention and motor responses by means of event related potentials. Healthy volunteers were examined in double blind, placebo 
controlled study. EEG recordings from 32 channels were performed in three sessions: before the supplementation (session 1), 30 min 
after the supplementation (session 2) and 90 min after the supplementation (session 3) in three tasks: visual P3, auditory P3, and motor 
task. Repeated measures ANOVA analysis showed reduced P3 amplitude increase after energy dietary supplementation (compared 
to placebo group) throughout all sessions (up to 90 min after consumption) in the visual task, and speeding the classification process 
observed as a decrease of P3 midpoint latency, but only 30 min after supplementation. The latter effect was present in both, but more 
pronounced in the visual task. Nonparametric cluster based permutation analysis showed one significant cluster in the placebo group 
from visual P3 task (approximately between 400 and 520 ms) over the centro‑parietal area, which was absent in the study group. Our 
results suggest that caffeinated energy dietary supplement containing only 55 mg of caffeine may enhance some attentional processes 
observed by changes in P3 features, but not in motor performance.
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INTRODUCTION
Human cognition may be enhanced by energy drinks 
containing caffeine and/or other stimulants (such as 
taurine, vitamin B, guarana, yerba mate, acai, ginseng, 
maltodextrin, inositol, carnitine, creatine, glucurono‑
lactone, and ginkgo biloba), which are thought to im‑
prove cognitive performance, alertness, mood, atten‑
tional performance, increase wakefulness, help main‑
tain attentional focus, concentration, endurance infor‑
mation processing and vigilance, decrease fatigue, and 
reduce reaction times (Seidl et al., 2000; Kennedy et al., 
2004; Deslandes et al., 2005; Smith et al., 2005; Heckman 
et al., 2010; Alsunni, 2011; Gurley et al., 2015; Boolani et 
al., 2017; Socci et al., 2017; Karabay et al., 2018). 
The effects of caffeine are known to be dose relat‑
ed, where 200 mg is generally the optimal dose (Smith, 
2011). The amount of caffeine in coffee and other bev‑
erages differs due to serving size, but it usually ranges 
from 40 to 300 mg in coffee, from 9 to 50 mg in tea, from 
36 to 71 mg in Cola beverages, and from 70 to 200 mg in 
energy drinks (Higgins et al., 2010; Wesnes et al., 2013). 
What’s interesting, literature shows that even low 
doses of caffeine may improve cognitive performance 
(Smit and Rogers, 2000). Moreover, previous studies 
showed stimulatory effects after supplementation with 
a level of caffeine, which are generally considered to 
be too low to be functionally active. These studies in‑
dicated that the evinced effects are not attributable to 
caffeine content alone. Adequate levels of vitamins and 
minerals are also essential for the optimal performance 
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of many physiological processes (Huskisson et al., 2007; 
Kennedy et al., 2008; White et al., 2017). 
However, some reports indicate these benefits of 
energy drinks may be limited to improvements in sub‑
jective state only, not extended to objective perfor‑
mance (Gurley, 2015) or the doses used in the studies 
are above normal. Therefore, the aim of this study was 
to examine the acute effect of energy boost dietary 
supplement in the form of an effervescent tablet dis‑
solved in water, containing 55 mg of caffeine, guara‑
na, yerba matte, cocoa powder and vitamin B on brain 
electrophysiological activity. We investigated whether 
a single dose of such a supplement shows an effect on 
an attention and motor responses by means of dou‑




The experiment was conducted on 47 young, healthy 
people (27 women) at the age of 26.1±4.6 years. They 
were students or university alumni, right handed, had 
normal color perception and normal or corrected to 
normal visual acuity, as well as normal blood pressure 
and body temperature at the day of the study. All the 
participants were healthy, physically active, non‑smok‑
ers, moderate caffeine users and had no neurological 
medical history. Information about their health con‑
dition and life style was gathered in a questionnaire. 
None of the participants had consumed alcohol, cof‑
fee, intoxicant, energizing beverages or other such 
substances within 12 h prior to the study. They were 
also asked to get rest, not to participate in a party or 
other tiring events and not to consume large amounts 
of alcohol within 24 h before the examination. The ex‑
periment was conducted with the understanding and 
written consent of each subject, according to the Code 
of Ethics of the World Medical Association. The stud‑
ies have been approved by the Committee of Ethics of 
University of Silesia on scientific studies conducted on 
humans (number 1/2018).
Study design
Double blind, placebo controlled study was used, 
where neither the participants, nor data collectors knew 
which group the particular participant belonged to. 
Half of the participants (study group) received the 
active substance. They drank one cup of water with dis‑
solved one effervescent tablet of energy boost dietary 
supplement. The tablet contained a total amount of 
55 mg of caffeine, including caffeine extract, guarana, 
yerba matte, cocoa powder, vitamin B and other vita‑
mins and minerals. 
The other half (placebo group) receives a placebo 
designed to appear, as much as possible, like the active 
substance. They drank one cup of water with dissolved 
one effervescent tablet containing vitamin C in the sim‑
ilar dose as was in the dietary supplement. The drinks 
in both groups had the same taste, smell and color. 
Individuals in both groups didn’t know whether 
they are getting the active substance or placebo. Fur‑
thermore, the researchers conducting the measure‑
ments were also kept in the dark about which group 
is receiving which treatment. The treatment (active 
substance or placebo) was assigned at random by the 
researcher who did not conduct the measurements. 
EEG recordings were performed in three sessions: 
before the supplementation (session 1), 30 min after 
the supplementation (session 2) and 90 min after the 
supplementation (session 3). The study design is pre‑
sented in Fig. 1. 
In each session, there were 7 tasks performed, 
among which there were three tasks which are ana‑
lyzed in this paper: visual P3 task, auditory P3 task and 
motor task. Each task lasted around 5 min. There were 
1‑2 minute breaks between the tasks and longer breaks 
between sessions (around 30 min between session 1 and 
2 and around 20 min between session 2 and 3). The ex‑
periment started at the same time of the day (2 pm ± 
2 h), due to the fact that circadian rhythm may influ‑
ence human cognition (Polich and Kok, 1995).
Stimuli and task
The participants were seated in a comfortable chair 
in front of the computer screen in a distance of 1 m, in 
a dimmed room. The P3 tasks were oddball paradigms 
to stimulate participants with the visual stimuli pre‑
sented on the 19 inch LCD monitor and with the au‑
ditory stimuli presented in headphones. The scenarios 
were created using Eevoke software (ANT Neuro). 
In the visual task, participants were instructed to 
gaze on the center of the black screen during inter‑
stimulus interval and to observe letters and numbers 
presented in the center of the screen (yellow font on 
a black background). Letters were standard stimuli and 
numbers were target stimuli. The parameters of the 
stimuli were: 200 ms duration and 1000±200 ms inter‑
stimulus interval. 
In the auditory task, participants were instructed to 
listen to two tones presented in the headphones, where 
1000 Hz tone was a standard stimulus and 2000 Hz was 
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a target stimulus. The parameters of the stimuli were: 
100 ms duration and 1000±200 ms interstimulus interval. 
In both tasks the stimuli were presented in ran‑
dom order in each session, for each participant. Their 
probabilities were: 20% for target and 80% for standard 
stimuli. The overall number of stimuli were 250 (200 
standard and 50 target stimuli) and participants were 
instructed to push a pad button after each target stim‑
ulus. In the motor task, a small white cross in the cen‑
ter of a black background was presented in random in‑
terstimulus intervals. The participants were instructed 
to push a pad button as quickly as possible after each 
presentation.
EEG recording and analysis
Before putting the electrodes on, Everi (Spes Med‑
ica s.r.l.) abrasive and conductive paste was used to 
clean the skin on the forehead. Continuous EEG was 
recorded from 32 Ag/AgCl electrodes embedded in an 
elastic WaveguardTM EEG cap (using extended 10/20 
EEG montage system) with AFz electrode as the ground 
electrode. OneStep Clear Gel (ANT Neuro) was insert‑
ed into electrodes in order to provide contact between 
skin and electrodes. The impedances at each electrode 
site were kept below 5 kΩ. 
The signals were recorded using common average 
reference and then re‑referenced offline to the average 
of the left and right mastoid electrodes. The signal was 
collected by means of ANT Neuro amplifier (AMP‑TR‑
F40AB model) in DC with 20000 amplification gain and 
256 Hz sampling rate. Advanced Source Analysis system 
ASA‑Lab (ANT Neuro) with ASA v.4.8 software was used 
for acquisition. No high‑pass filter was applied during 
data acquisition.
Offline data processing was performed using the 
EEGLAB (Delorme and Makeig, 2004) and ERPLAB Tool‑
boxes (Lopez‑Calderon and Luck, 2014), which are 
open‑source Matlab packages for EEG‑ERP analysis. 
Recorded EEG signals were filtered using high‑pass 
non‑causal Butterworth filter (with 0.1 Hz half‑am‑
plitude cutoff and 12 dB/octave slope). 30 Hz low‑pass 
filter was used for figures preparation only. The frag‑
ments of signal with clear, distinct artifacts were re‑
jected manually. In order to correct for eye blinks, in‑
dependent component analysis (ICA) was conducted 
using EEGLAB’s runica algorithm. The criterion for re‑
jecting the components was: the anterior scalp distri‑
bution, the location in ERP image and the spectral his‑
togram of independent components (ICs). One or two 
components for each participant were identified. 
Continuous signal was then epoched starting 200 ms 
before the stimulus (baseline) and ending at 800 ms af‑
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Fig. 1. Study design. EEG recordings were performed in three sessions: before the supplementation (session 1), 30 min after the supplementation 
(session 2) and 90 min after the supplementation (session 3).
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ter stimulus presentation. Trials with incorrect behav‑
ioral responses or eye blinks occurring during stimulus 
presentation (i.e. from ‑200 ms before to 200 ms after 
the stimuli) were excluded from averages. Artifact re‑
jection was applied using ERPLAB’s moving window 
peak‑to‑peak threshold tool. Trials which peak‑to‑peak 
voltage exceeded 100 µV in 200 ms time windows (with 
50 ms window step) were detected and excluded from 
the analysis. 
In the final step of the analysis, the individual ERP 
waveforms were grand averaged in order to obtain 
mean ERPs for each experimental condition. Only sub‑
jects whose minimal number of trials after rejection 
was 30 were included in the analysis. This resulted in 
excluding 7 participants from further analyses. Mean 
number of standard and target stimuli after data pro‑
cessing were: 173±26 and 48±3 for visual P3 task, and 
179±24 and 46±4 for auditory P3 task, respectively. 
Mean number of excluded standard and target error 
trials were: 27±26 and 2±3 for visual P3 task, and 21±23 
and 4±4 for auditory P3 task, respectively.
The P3 measurements were taken from target‑mi‑
nus‑standard difference waveforms. The amplitudes 
were measured as the mean voltage in a given window. 
In order to avoid biasing the results by using the dif‑
ference between conditions to define time window, we 
collapsed the ERPs across conditions and then defined 
the time window for P3 amplitude as 350‑700 ms for 
visual task and 250‑700 ms for auditory task. In addi‑
tion, we also used a narrower time window: 350‑550 ms 
for visual and 250‑450 ms for auditory task. For the P3 
latency measurements, 50% area latency was used as 
the midpoint latency (the time point that divided the 
area under the curve into two equal halves) within time 
window 300‑500 ms for visual task and 200‑400 ms for 
auditory task, using only positive values (negative val‑
ues were zeroed). This approach is similar to measur‑
ing peak latency, but has several advantages, including 
greater statistical power (Luck and Kappenman, 2009).
Statistical analysis
In the statistical analysis, following dependent vari‑
ables were compared: mean P3 amplitude within the 
defined time windows taken from the difference ERP 
waveforms as the measure of P3 amplitude, and mid‑
point latency as the measure of the P3 latency.
Repeated measures ANOVA included between‑sub‑
ject factor: GROUP (placebo and study) and within‑sub‑
ject factors: SESSION (session 1, session 2 and session 
3), AREA (frontal, central and parietal) and HEMI‑
SPHERE (left, midline, right). The Greenhouse‑Geisser 
correction for nonsphericity and post‑hoc compar‑
isons with Bonferroni correction were used. In ad‑
dition, when the assumption of the sphericity of the 
data was violated, multivariate Wilk’s lambda test was 
used as an additional confirmation of the obtained cor‑
rected univariate results. For data which didn’t fulfill 
the normal distribution and variance homogeneity as‑
sumptions, nonparametric Friedman’s test was used. 
In all the analyses, P<0.05 was regarded as statistically 
significant.
In order to take a deeper insight into the changes of 
ERPs throughout the sessions, we compared ERPs be‑
tween sessions, time point by time point, using non‑
parametric cluster based permutation analysis (Maris 
and Oostenveld, 2007). Monte Carlo correction for MCP 
(multiple comparison problem) was used by means of 
FieldTrip software, which is an open source Matlab 
toolbox for MEG, EEG, iEEG and NIRS analysis (Oosten‑
veld et al., 2011). This method allowed us to compare 
ERP trials between sessions for both groups (placebo 
and study) and both tasks (visual and auditory) for each 
(channel,time) pair and to identify statistically mean‑
ingful spatiotemporal clusters. Cluster alpha P=0.05 
and 0‑700 ms time window were used. Since there were 
three experimental conditions in our study (‘session 1’, 
‘session 2’ and ‘session 1’), they were compared for ev‑
ery (channel, time) pair, by means of F‑statistic (alpha 
0.05), using ft_statfun_depsamplesFmultivariate func‑
tion. Cluster‑level statistics were calculated by taking 
the sum of the F‑values within every cluster and the 
maximum of the cluster‑level statistics was taken. 2000 
draws from the permutation distribution were used. 
Channel neighbors for spatial clustering were found 
based on the triangulation method.
The analysis consisted of a comparison of behavior‑
al data and ERPs throughout sessions, between placebo 
and study groups, taking into account location of the 
electrodes (area and hemisphere factors). First, behav‑
ioral results were presented followed by ERPs results. 
Within the ERPs analyses, the P3 amplitudes were first 
analyzed for the visual and auditory tasks. Then, mid‑
point latencies were analyzed for the same tasks. At the 
end, nonparametric cluster‑based permutation results 
were presented.
Biological and environmental determinants  
of P3 waveform
P3 waveform indexes brain activities underlying 
attention, which can be influenced by many natural 
and environmental factors, such as: circadian rhythm, 
body temperature, heart rate, food intake, activity 
time, age, fatigue, nicotine and alcohol intake, arousal, 
and anxiety (Polich and Kok, 1995; Guerra et al., 2016; 
414 Acta Neurobiol Exp 2020, 80: 411–423
Energy dietary supplementation and P3 waveformActa Neurobiol Exp 2020, 80
Vazquez‑Marrufo, 2017). Moreover, other factors may 
also influence reliability of the results: subject char‑
acteristics (e.g. caffeine usage levels), proper dosage, 
abstinence period before examination, and expectan‑
cy effect (Barry et al., 2007). We therefore took care 
to control for the aforementioned factors. In order to 
control for the circadian rhythm differences, we con‑
ducted the experiments at the same time of a day for 
each participant (2 pm ± 2 h). Body temperature and 
heart rate, as the physical measures of arousal, were 
measured before and after each session. 
All the subjects were moderate caffeine consum‑
ers, non‑smokers, and had restrained from energy 
beverages and alcohol long enough before the exam‑
ination to get rid of previous contamination. They 
were also asked not to consume heavy meals at the 
day of the study.
Fatigue and stress level were assessed by partici‑
pants in the questionnaire. They determined fatigue 
level prior to the examination on a 1‑4 scale. They also 
determined their overall anxiety (how stressful they 
are in social and everyday life). The latter factor was 
assessed with the use of 10 questions, which the partic‑
ipants answered on a 1‑4 scale: ‘almost never’, ‘some‑
times’, ‘often’ and ‘almost always’. The questions were 
based on Spielberger’s State‑Trait Anxiety Inventory 
test and concerned stressful situations in everyday life 
or assessment of general anxiety, e.g. ‘I feel nervous 
or restless’ or ‘I feel stressed about what other people 
think about me’ (Spielberger, 1983; Dionne, 2015). 
Neither age, nor any of the initial values of the above 
mentioned factors: body temperature, heart rate, fatigue, 
and anxiety level measured prior to the experiment, dif‑
fered between placebo and study groups (Table I). 
In order to investigate potential effects declared 
by the manufacturer (energy boost, decreased fatigue 
and improved concentration and vigilance) for the 
realistic dose of the supplement, we conducted the 
measurements after single dosage, in two time points 
(30 min and 90 min after consumption) and compared 
the measures in addition to pre‑task condition. More‑
over, in order to notice potential stimulatory effects, 
which according to the literature manifest mainly in 
fatigue state, we conducted the experiment in the 





The reaction times (RT) and correct response rates 
(CR) were calculated for both: P3 visual and P3 auditory 
task, as well as for the motor response task. In each of 
the three tasks, there was no significant change in RT 
between three sessions, neither for the main effect SES‑
SION, nor for the interaction effect SESSIONxGROUP. 
The statistical results are gathered in Table II. Correct 
response rate for both P3 tasks did not change be‑
tween sessions either.
Electrophysiological data
There were 21 subjects in placebo group and 19 sub‑
jects in the study group included in the analyses for 
each P3 task. Fig. 2 presents ERP difference waveforms 
from all three sessions, for both: visual and auditory 
P3 tasks, for placebo and study groups, measured from 
frontal, central and parietal electrodes.
A clear P3 peak is present, arising after 300 ms in vi‑
sual and auditory P3 tasks. The P3 amplitude increased 
from frontal through central to parietal areas. There 
are also N1, P2 and N2 peaks visible. In the upper part 
of the figure (Fig. 2A), an increase of P3 amplitude be‑
tween sessions in placebo group in the visual task can 
be seen over central and parietal areas, whereas P3 am‑
plitudes in the study group are much more similar. In 
the lower part of the figure (Fig. 2B) showing ERPs from 
auditory task, differences in P3 amplitude between ses‑
sions are smaller. Further statistical analysis will show 
whether these observations are significant.
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Table I. Statistical results of biological measures comparisons between placebo and study groups.
Mean placebo Mean study t value p
Age 26.6 25.5 0.64 0.52
Fatigue level 2.9 2.8 0.49 0.63
Body temperature 36.5 36.4 0.65 0.52
Heart rate 71.5 73.4 ‑0.66 0.52
Anxiety level 1.9 2.0 ‑0.35 0.73
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Fig. 2. Grand averaged difference ERPs from visual (A) and auditory (B) P3 tasks, measured at: F3, Fz, F4, C3, Cz, C4, P3, Pz and P4 electrode sites, for: session 
1 from placebo group (p1), session 2 from placebo group (p2), session 3 from placebo group (p3), session 1 from study group (s1), session 2 from study 
group (s2), and session 3 from study group (s3).
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P3 amplitude analysis
Visual task
Fig. 3 presents mean P3 amplitudes from the visu‑
al task, for all three sessions, within 350‑550 ms and 
350‑700 ms time windows. First row shows the SESSION 
effect, second row shows the SESSIONxGROUP effect, 
and third row shows the SESSIONxGROUPxAREA effect.
There were no significant differences in the mean 
P3 amplitude within 350‑700 ms time window be‑
tween sessions, however a tendency of its increase in 
placebo (but not in the study) group over central and 
parietal areas was observed (Fig. 3D‑F).
When narrower time window was applied 
(350‑550 ms), statistical analysis revealed main effect 
SESSION, which showed that mean P3 amplitude sig‑
nificantly increased between sessions (Fig. 3A). More 
importantly, interaction effects SESSIONxGROUP (with 
post‑hoc significant differences observed only in place‑
bo group) as well as SESSIONxAREA (with post‑hoc sig‑
nificant differences observed over central and parietal 
areas) were also observed. Mean P3 amplitude increased 
significantly throughout sessions only in placebo group 
(Fig. 3B). Though the SESSIONxGROUPxAREA effect 
was not significant, mean P3 amplitude tendency to in‑
crease over central and parietal areas may be observed, 
with a steeper increase in the placebo than in the study 
group (Fig. 3C). Differences in the P3 amplitude between 
session 1 and session 3 were: 1.8±3.0 µV over central 
area and 1.9±2.6 over parietal area in the placebo group 
and 1.1±3.0 µV over central area and 0.6±2.5 µV over pa‑
rietal area in the study group. The statistical results of 
this analysis are presented in Table III.
An additional comparison of P3 amplitude differ‑
ences between session 3 and session 1 (P3diff=P3session3 – 
P3session1) revealed main effect GROUP (F1,342=6.5, p=0.01) 
and AREA (F2,342=6.0, p=0.0026) showing that the P3 am‑
plitude increase is significantly smaller in the study 
group than in the placebo group. Moreover, the differ‑
ences in P3diff between the placebo and the study group 
became bigger from frontal to parietal area. 
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Table II. Statistical results of RT comparisons between sessions in P3 visual, P3 auditory and motor tasks.










Table III. Statistical results of the P3 amplitude analysis in the 350‑550 ms time window in the visual task.
Effect
Statistical results
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Fig. 3. Mean P3 amplitudes from the visual task, in session 1 (s1), session 2 (s2) and session 3 (s3), from placebo (gray) and study (black) groups, measured 
within 350‑550 ms (left panel) and 350‑700 ms time window (right panel). First row (A and D) shows the SESSION effect, second row (B and E) shows the 
SESSIONxGROUP effect, and third row (C and F) shows the SESSIONxGROUPxAREA effect. Bars: 0.95 confidence level. Significant differences with p<0.05 
are marked with an asterisk.
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Auditory task
In the auditory task, the P3 amplitude changes 
throughout sessions were similar in the placebo and 
the study groups, for both time windows (Fig. 4). 
For 250‑700 ms time window, there was only main 
effect SESSION (Fig. 4D) and interaction effect SES‑
SIONxAREA (with post‑hoc significant differences ob‑
served only over frontal area) observed. For 250‑450 ms 
time window, there was neither significant main effect 
SESSION, nor any interaction effect seen (Fig. 4A‑C). 
The statistical results are presented in Table IV.
P3 latency analysis
Since P3 latencies didn’t fulfill variance homoge‑
neity criterion, all the comparisons were performed 
using non‑parametric ANOVA Friedman’s tests. Due to 
the fact that calculating latencies is not trivial and it 
may be biased by the noise in data (Luck, 2014), this 
analysis was performed only on the data with clear P3 
peak. Therefore, only 23 subjects from each (visual and 
auditory) task were included in this part of the analy‑
sis. Fig. 5 presents mean P3 midpoint latency chang‑
es throughout sessions from the visual (Fig. 5A‑B) and 
auditory (Fig. 5C‑D) tasks, in the placebo and study 
groups, for SESSIONxGROUP effect (upper row), and 
SESSIONxGROUPxAREA effect (lower row).
Visual task
In the P3 visual task, midpoint latency changed dif‑
ferently in the experimental groups: in the placebo group 
it was the highest in session 2, Χ2 (2, N=78)=14, p=0.00093, 
whereas in the study group it was the lowest in session 2, 
Χ2 (2, N=84)=10.3, p=0.0059 (Fig. 5A). Moreover, these differ‑
ences were seen on the area level as well, where a difference 
in the placebo group was significant only over central area, 
Χ2 (2, N=27)=8.4, p=0.015, and differences in the study group 
were significant over central, Χ2 (2, N=30)=7.1, p=0.028 and 
parietal areas, Χ2 (2, N=33)=7.3, p=0.025 (Fig. 5B).
Auditory task
In the P3 auditory task, the midpoint latency 
didn’t change between sessions in the placebo group, 
Χ2 (2, N=108)=2.6, p=0.27, but in the study group it de‑
creased in session 2 and then returned in session 3 to 
the same level as in session 1, Χ2 (2, N=75)=9.1, p=0.01 
(Fig. 5C). However, no significant changes were ob‑
served at the area level (Fig. 5D).
Nonparametric cluster‑based  
permutation analysis
Due to the fact that ERPs have advantage of high 
temporal precision, we performed nonparametric clus‑
ter‑based permutation tests (Maris and Oostenveld, 
2007) to compare ERPs between sessions, time point by 
time point, using Monte Carlo correction for MCP. The 
MCP arises from the fact that the effect of interest (i.e. 
a difference between experimental conditions) is eval‑
uated at a large number of (channel, time)‑pairs. Using 
multivariate test for within‑subject EEG study, a null 
hypothesis about the probability distributions of the 
session‑specific averages was tested. This hypothe‑
sis involved that trial specific data structures from all 
three sessions (i.e. trials from ‘session 1’, ‘session 2’, 
and ‘session 3’) were drawn from the same probability 
distribution, regardless of the experimental condition. 
The analysis combines neighboring values that are like‑
ly to be correlated (e.g., neighboring time points and 
spatial locations) to reduce the MCP. Using cluster al‑
pha p=0.05, we found a significant difference between 
ERPs from ‘session 1’, ‘session 2’ and ‘session 3’ trials 
only in placebo group from the visual P3 task. This dif‑
ference resulted in one significant cluster (p=0.003), 
which extended from approximately 400 to 520 ms over 
the centro‑parietal area. There were no other signifi‑
cant results. A topomap showing cluster based permu‑
tation test results with highlighted significant cluster 
for P3 visual task from placebo group is presented in 
Fig. 6.
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Table IV. Statistical results of the P3 amplitude analysis in the 250‑700 ms time window in the auditory task.
Effect
Statistical results
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Fig. 4. Mean P3 amplitudes from the auditory task, in session 1 (s1), session 2 (s2) and session 3 (s3), from placebo (gray) and study (black) groups, 
measured within 250‑450 ms (left panel) and 250‑700 ms time window (right panel). First row (A and D) shows the SESSION effect, second row (B and E) 
shows the SESSIONxGROUP effect, and third row (C and F) shows the SESSIONxGROUPxAREA effect. Bars: 0.95 confidence level. Significant differences 
with p<0.05 are marked with an asterisk.
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Fig. 5. P3 midpoint latencies measured in session 1 (s1), session 2 (s2) and session 3 (s3), from placebo (gray) and study (black) groups, in visual (left panel) 
and auditory (right panel) tasks. First row (A and C) shows the SESSIONxGROUP effect, and second row (B and D) shows the SESSIONxGROUPxAREA effect. 
Bars: 0.95 confidence level. Significant differences with p<0.05 are marked with an asterisk.
Fig. 6. Topographic distributions of the differences between condition‑averaged ERPs: ‘session 1’, ‘session 2’ and ‘session 3’ trials for P3 visual task from 
placebo group, at p<0.05, cluster corrected. Electrode clusters on the basis of which the null hypothesis was rejected are highlighted with asterisks. For 
each panel all time points and all 30 electrodes were included in the permutation test. Bars show F‑values.
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DISCUSSION
The amplitude and latency of P3 waveform give two 
different sources of information about the classifica‑
tion process that is engaged in attention during per‑
forming the task. P3 amplitude is larger when more ef‑
fort is devoted to the task, what has been described as 
resource allocation (Polich, 2007). 
In our study, P3 amplitude in visual task in the pla‑
cebo group tended to increase throughout sessions 
within 350‑700 ms time (Fig. 3E) and significantly in‑
creased (Fig. 3B) when narrower (350‑550 ms) time win‑
dow was used. This increase, though not significant at 
the area level, was observed over central and parietal 
areas (Fig. 3C and 3F). Moreover, nonparametric clus‑
ter‑based permutation analysis showed a significant 
cluster between approximately 400 and 520 ms over 
centro‑parietal area in this group (Fig. 6). According 
to Luck (2014), P3 amplitude depends on: uncertainty, 
probability, and resource allocation. Since in our ex‑
periment neither uncertainty nor probability changed 
between sessions, we considered this increase of P3 
amplitude between sessions in the placebo group as 
an effect of increased amount of resources allocated to 
perform the task. We regarded this increase as a result 
of increasing mental fatigue caused by having to com‑
plete many tasks during a long experimental time.
No significant increase of the mean P3 amplitude 
was observed in the study group within 350‑700 or 
350‑550 ms time windows (Fig. 3B‑F). The cluster‑based 
analysis didn’t reveal any significant clusters in the 
study group, either. This means that the increase of P3 
amplitude throughout sessions was reduced after ener‑
gy dietary supplementation. 
Interestingly, in auditory task no such behavior was 
observed – the mean amplitude changed between ses‑
sions in the same way in the placebo and the study 
groups (Fig. 4). 
One of the possible explanations of the obtained re‑
sults is that caffeinated energy dietary supplement de‑
creased fatigue level in the visual task, which caused 
fewer sources needed to be allocated to perform the task.
On the other hand, P3 latency is thought to index 
classification speed, which is proportional to the time 
required to detect and process a target item (Kutas et 
al., 1977; Magliero et al., 1984). 
Midpoint latency in the visual task in the placebo 
group was the highest in session 2 compared to session 
1 and 3 (Fig. 5A), with significant difference over cen‑
tral area (Fig. 5B). On the contrary, in the study group, 
there was a drop in midpoint latency in session 2 (FIG. 
5A), which was significant in both: central and parietal 
areas (Fig. 5B). In the auditory task, midpoint latency 
didn’t change throughout sessions in placebo group, 
but it dropped in study group in session 2 (though only 
SESSIONxGROUP effect was significant, Fig. 5C‑D). This 
decrease in P3 midpoint latency in the study group 
means that the energy dietary supplement speeded up 
the classification process in both tasks, but more visi‑
ble in the visual task. However, this effect was observed 
only 30 min after supplementation. In the session 3 
(90 min after supplementation) midpoint latency was 
on the similar lever to the pre‑supplementation level. 
Caffeine is rapidly absorbed from the digestive tract 
and distributed to all tissues, including the brain. The 
peak plasma concentration is achieved 30 to 120 min af‑
ter oral intake and the plasma half‑life has been report‑
ed to vary from 3 to 10 h depending upon the individual 
(Babu et al., 2008; Wesnes et al., 2013). Literature indi‑
cates that the energy drinks help maintain attentional 
focus, concentration, information processing and vigi‑
lance over the 6 h period. Such a short time of action of 
the energy dietary supplement in our study may be con‑
nected to a lower dose of caffeine present in the drink. 
The fact that different behavior of the changes of 
P3 features was observed in visual and auditory task 
is interesting. Though P3 is an event related potential, 
which doesn’t rely on physical parameters of the stim‑
uli, differences in its features between modalities have 
been observed (Dreo et al., 2016). However, there might 
have been task difficulty confound, since there were 
only two kinds of stimuli: 1000 and 2000 Hz tones in 
auditory task, while in the visual task, participants had 
to classify many letters and numbers. 
What’s important, no changes were observed in the 
motor task. These results suggest that the aforemen‑
tioned effects relate to classification process and not 
to response preparation. Moreover, the lack of effect of 
energy dietary supplementation on changes in RT and 
CR between sessions (Table II) suggests that electro‑
physiological features are more sensitive to lower dos‑
es of cognitive stimulants than behavioral measures.
In conclusion, the energy dietary supplementation 
lowered a P3 mean amplitude increase throughout the 
whole experiment (3 sessions) in the visual task, com‑
pared to the placebo group. This result was considered 
as a reduction of mental fatigue. The energy dietary 
supplementation also speeded classification process 
in both visual and auditory tasks through lowering the 
P3 midpoint latency, but only 30 min after supplemen‑
tation. This result was present in both, but more pro‑
nounced in the visual task.
CONCLUSIONS
A single dose of an energy dietary supplement con‑
taining 55 mg of caffeine (in the form of caffeine ex‑
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tract, guarana, yerba matte, cocoa powder, vitamin B 
and other vitamins and minerals), reduced P3 ampli‑
tude increase (compared to placebo group) throughout 
all sessions (up to 90 min after consumption) in the 
visual task. Nonparametric cluster‑based permuta‑
tion analysis of ERP waveforms from a visual task con‑
firmed this result showing a significant cluster, which 
corresponded to the P3 time window (approximately 
400‑520 ms) over centro‑parietal area only in placebo 
group. Since the P3 amplitude is recognized as the mea‑
sure of resource allocation, this reduction of P3 ampli‑
tude increase may be explained by the fact that stim‑
uli categorization in sessions following energy dietary 
supplementation was less effortful than in the placebo 
group. Moreover, the energy boost supplementation 
caused speeding of the classification process observed 
as a decrease of P3 midpoint latency, but only 30 min 
after supplementation. This result was present in both, 
but more pronounced in the visual task. ERP from mo‑
tor task didn’t change significantly between sessions. 
Performance measured by response time and accuracy 
was maintained at the same level throughout sessions 
in both: placebo and study groups, in all three tasks.
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